HHC
USNA icon

Hutchin Hill Capital’s Usana Health Sciences USNA Stock Holding History

Hutchin Hill Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,400
Closed -$714K – 1055
2017
Q1 		$714K Buy
+12,400
New +$740K 0.02% 549
2015
Q3 		– Sell
-19,000
Closed -$1.3M – 757
2015
Q2 		$1.3M Sell
19,000
-7,200
-27% -$457K 0.03% 399
2015
Q1 		$1.46M Buy
26,200
+9,158
+54% +$469K 0.04% 367
2014
Q4 		$874K Buy
+17,042
New +$837K 0.03% 350

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hutchin Hill Capital's USNA Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Usana Health Sciences (USNA) in Q2 2017, closing a stake of 12,400 shares — an estimated $714K sold.

Hutchin Hill Capital first reported a position in USNA in Q4 2014 and held it in 4 quarters. The position peaked at $1.46M in Q1 2015. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

  • Hutchin Hill Capital reported no remaining Usana Health Sciences position as of Q2 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 12,400 Usana Health Sciences shares in Q2 2017, an estimated $714K.
  • Hutchin Hill Capital first reported a position in Usana Health Sciences in Q4 2014 and held it in 4 quarters.
  • Hutchin Hill Capital's Usana Health Sciences position peaked at $1.46M in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.